Drug repurposing for the treatment of staphylococcal infections

S Thangamani, H Mohammad… - Current …, 2015 - ingentaconnect.com
The development and approval of new antimicrobials capable of being used to treat
infections caused by multidrug-resistant pathogens has not kept pace with the rapid …

Drug Repurposing: A new Front in the War Against Staphylococcus Aureus

S Das, A Dasgupta, S Chopra - Future microbiology, 2016 - Taylor & Francis
Staphylococcus aureus continues its domination of worldwide bacterial infection rates,
thereby remaining a pathogen of significant public health interest. A major reason for its …

Repurposing of Drugs for Antibacterial Activities on Selected ESKAPE Bacteria Staphylococcus aureus and Pseudomonas aeruginosa

B Kamurai, M Mombeshora… - International Journal of …, 2020 - Wiley Online Library
Increasing cases of multidrug‐resistant pathogens have evolved into a global health crisis.
ESKAPE group of bacteria are associated with antibiotic resistance, and infections caused …

Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections

A Rangel-Vega, LR Bernstein… - Frontiers in …, 2015 - frontiersin.org
Bacterial infection remains one of the leading causes of death worldwide, and the options for
treating such infections are decreasing, due the rise of antibiotic-resistant bacteria. The …

Novel antimicrobial strategies to treat multi‐drug resistant Staphylococcus aureus infections

EJA Douglas, SW Wulandari, SD Lovell… - Microbial …, 2023 - Wiley Online Library
Antimicrobial resistance is a major obstacle for the treatment of infectious diseases and
currently represents one of the most significant threats to global health. Staphylococcus …

Emerging drugs for treating methicillin-resistant Staphylococcus aureus

M Bassetti, A Russo, A Carnelutti… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: In clinical practice, methicillin-resistant Staphylococcus aureus (MRSA)
represents a major threat and has been associated with high rates of inadequate antibiotic …

Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections

M Magana, A Ioannidis, E Magiorkinis… - Current …, 2015 - ingentaconnect.com
Methicillin-resistant Staphylococcus aureus (MRSA) remains the single biggest challenge in
infectious disease in the civilized world. Moreover, vancomycin resistance is also spreading …

Surmounting antimicrobial resistance in the millennium superbug: Staphylococcus aureus

S Saxena, C Gomber - Open Medicine, 2010 - degruyter.com
Staphylococcus aureus is the third most dreaded pathogen posing a severe threat due to its
refractory behavior against the current armamentarium of antimicrobial drugs. This is …

Drug repurposing for the treatment of bacterial and fungal infections

A Miró-Canturri, R Ayerbe-Algaba… - Frontiers in microbiology, 2019 - frontiersin.org
Multidrug-resistant (MDR) pathogens pose a well-recognized global health threat that
demands effective solutions; the situation is deemed a global priority by the World Health …

Staph wars: the antibiotic pipeline strikes back

EJA Douglas, M Laabei - Microbiology, 2023 - microbiologyresearch.org
Antibiotic chemotherapy is widely regarded as one of the most significant medical
advancements in history. However, the continued misuse of antibiotics has contributed to the …